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Indirect antiglobulin test-crossmatch 
using low-ionic-strength saline–albumin 
enhancement medium and reduced incubation 
time: effectiveness in the detection of most 
clinically significant antibodies and impact on 
blood utilization
C.L. Dinardo, S.L. Bonifácio, and A. Mendrone, Jr.
Indirect antiglobulin test-crossmatch (IAT-XM) using 
enhancement media such as low-ionic-strength saline (LISS) 
and polyethylene glycol (PEG) usually requires 15 minutes of 
incubation. These methods are necessary when testing samples 
from blood recipients who have a higher risk of alloimmunization. 
In emergency situations, IAT-XM can be time-consuming and 
can influence presurgery routine, resulting in more red blood cell 
(RBC) units being tested and stored to avoid the transfusion of 
uncrossmatched ones. The objective of this study was to evaluate 
the performance of a LISS-albumin enhancer to intensify 
antigen-antibody reaction after 5 minutes of 37°C incubation and 
compare this performance with that of other enhancers, gel, and 
conventional tube testing. Second, the study evaluated the impact 
of this method’s implementation in the C:T ratio (crossmatched 
to transfused RBC units) of a transfusion laboratory. Ninety 
serum samples containing alloantibodies of potential clinical 
significance were tested against phenotyped RBCs using four 
different methods: (1) tube with LISS-albumin enhancer 
(5 minutes of incubation), (2) tube with LISS-albumin and PEG 
(15 minutes of incubation), (3) gel, and (4) conventional tube 
method (60 minutes of incubation). In parallel, the study compared 
the C:T ratio of a tertiary-hospital transfusion laboratory in 
two different periods: 3 months before and 3 months after the 
implementation of the 5-minute IAT-XM protocol. The use of 
LISS-albumin with 5 minutes of incubation exhibited the same 
performance as LISS-albumin, PEG, and gel with 15 minutes 
of incubation. Conventional tube method results were equally 
comparable, but reactions were significantly less intense, except 
for anti-c (p = 0.406). Accuracy was 100 percent for all selected 
methods. After the implementation of the 5-minute IAT-XM 
protocol, the C:T ratio fell from 2.74 to 1.29 (p < 0.001). IAT-XM 
can have its incubation time reduced to 5 minutes with the use 
of LISS-albumin enhancement. We suggest this strategy should 
be used to quickly prepare RBC units for surgical patients, 
keeping transfusion safety without compromising blood supplies. 
Immunohematology 2014;30:1–5.
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Crossmatching of donor red blood cells (RBCs) and 
recipient’s serum is an important step required to complete 
pretransfusion tests. Crossmatch can be performed 
electronically or by an immediate-spin method, in which 
no incubation or anti-human globulin (AHG) steps are 
performed. Those modalities of crossmatch are applied to 
nonalloimmunized recipients, with the detection of ABO 
mismatches their main goal. Whenever there is a positive 
antibody screen (current or past) or a history of pregnancy, 
crossmatch demands 37°C incubation and AHG steps 
(indirect antiglobulin test-crossmatch; IAT-XM), increasing 
the time needed for completion of pretransfusion tests, which 
can become critical in emergency situations.
In Brazil, legislation requires IAT-XM for all recipients 
who have ever been transfused, pregnant, or alloimmunized, 
and as a consequence, the routine of performing a type and 
screen on samples from surgical patients is frequently not 
applied, as most transfusion laboratories perform IAT-XM 
before the surgery and segregate all the units that may be used 
during the surgical procedure until its end. This obviously 
increases the number of blood units in store and the costs 
of the pretransfusion tests. Also, the implementation of any 
automation may be compromised.
Classic saline indirect antibody test (SIAT) demands 60 
minutes of incubation (37°C) and three wash steps before 
the addition of AHG and interpretation of the results. This 
method allows 99 percent of antibody uptake onto RBCs for 
the detection of an immunoglobulin G (IgG) antibody present 
in the recipient’s serum.1 This length of incubation can be 
shortened with the help of enhancement media such as low-
ionic-strength saline (LISS), albumin, polyethylene glycol 
(PEG), and hexadimethrine bromide (Polybrene), whose 
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major functions are to speed up the rate of antigen-antibody 
association, promoting a higher rate of antibody uptake by 
RBCs in a shorter time.
In emergency situations, even when data referring to 
recipients’ previous alloimmunization is not known, saline 
immediate-spin crossmatch (IS-XM) is frequently chosen by 
laboratory analysts, as it allows fast availability of RBC units. For 
recipients who present a higher risk of alloimmunization, such 
as those with sickle cell anemia, myelodysplastic syndrome, 
or multiparity, this approach may be risky. Enhancement 
medium containing a mixture of LISS and albumin typically 
requires 15 minutes of incubation before the AHG phase. Our 
hypothesis is that this time can be shortened to 5 minutes 
without losing sensitivity, making this method suitable for 
RBC and serum crossmatch in emergency situations.
The main objective of this study is to evaluate the 
performance of a LISS-albumin enhancer to  intensify the 
antigen-antibody reaction after 5 minutes of 37°C incubation, 
allowing the detection of clinically significant alloantibodies 
present in recipients’ serum. Second, the impact of this method’s 
implementation in the routine of a transfusion laboratory will 
also be evaluated. To meet this second objective, we chose to 
evaluate the C:T ratio (ratio of units crossmatched to units 
transfused) before and after the implementation of the type 
and screen associated with the 5-minute IAT-XM protocol in 
our presurgery routine. In most countries, a C:T ratio less than 
2:1 is an indicator of efficient preparation of blood units for 
elective surgery.
Materials and Methods
Ninety serum samples containing alloantibodies of 
potential clinical significance (anti-D, -c, -K, -Jka, -Jkb, -Fya) 
from our inventory were tested against phenotyped RBCs 
using two different methods: tube and column agglutination 
gel (DiaMed Latino América, Lagoa Santa, Brazil). Tube testing 
was performed conventionally (without enhancers) and with 
two different enhancement media: LISS-albumin (Dialiss, 
DiaMed, enhancer 1, and LISS ADD, Lorne Laboratories, 
Lower Earley, UK, enhancer 2) and PEG (BioPeg, Fresenius 
HemoCare, São Paulo, Brazil, enhancer 3). One of the LISS-
albumin enhancers (enhancer 1) was chosen to be tested with 
the proposed protocol of 5 minutes of incubation. All tests 
were performed in parallel by the same analyst, according 
to the specific method described in a later section. We chose 
RBCs from donors who were heterozygous for the allele 
encoding the corresponding antigen against the alloantibody 
being tested.
Gel Microcolumn Assay Method
RBCs were washed once in 0.9 percent saline and 
suspended in LISS (ID-Diluent 2, DiaMed) to achieve a final 
0.8 to 1 percent concentration. Then 50 µL of 0.8 to 1 percent 
RBC suspension and 25 µL of sera were added to LISS-Coombs 
gel cards (IgG/C3d, DiaMed), incubated for 15 minutes at 
37°C, and centrifuged (85g) for 10 minutes according to 
manufacturer’s instructions.
Tube Testing
RBCs were washed three times in 0.9 percent saline 
and then adjusted to a final concentration of 3 percent. After 
this step, 50 µL of each RBC suspension and 100 µL of each 
specific serum were added to each tube. For the conventional 
method, tubes were incubated for 1 hour at 37°C. For the 
methods involving enhancers 2 and 3, tubes were incubated 
for 15 minutes at 37°C. After addition of enhancer 1, the tubes 
were incubated for 5 minutes at 37°C. After the incubation 
step, all tubes were washed three times with 0.9 percent saline 
before AHG was added and final reading of the results was 
performed. All reactions were read macroscopically. Positive 
reactions were graded from 1+ to 4+ and expressed in scores.2
Statistical Analysis
We compared the scores obtained from the five studied 
methods (median value) for each specific antibody using 
the Friedman statistical test (nonparametric statistical test 
suitable for multiple comparisons of different methods or 
treatments, SPSS version 17, SPSS Inc., Chicago, IL). We 
considered as statistically significant a probability value less 
than 0.05. Scores were calculated based on AABB standards.
Analysis of Crossmatched-to-Transfused Ratio
From June 2011 to September 2011, after the implemen-
tation of our new legislation, only an ABO/Rh type and antibody 
screen was performed for all preoperative transfusion requests 
(type and screen strategy), except in cases of alloimmunization, 
in which phenotyped units were prepared. If during the surgery 
any RBC unit was requested, our laboratory analysts performed 
the IAT-XM using the LISS-albumin enhancer and 5 minutes 
of 37°C incubation. We calculated the C:T ratio at the end of 
this 3-month period and compared it with our retrospective 
C:T ratio (March 2011 to May 2011).
Results
Enhancer 1 (LISS-albumin, 5 minutes of incubation), 
enhancer 2 (LISS-albumin, 15 minutes of incubation), 
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enhancer 3 (PEG, 15 minutes of incubation), and gel 
microcolumn agglutination methods exhibited similar 
performance, expressed in terms of score, for all selected 
antibodies. Conventional tube method results were equally 
comparable, but reactions were significantly less intense than 
those presented by the other methods, except in the case of 
anti-c (p = 0.406). Sensitivity and specificity were 100 percent 
for all selected methods. Enhancer 1 presented the highest 
scores in the presence of anti-Jkb, -c, -K, and -Fya. In the case 
of anti-D and -Jka, gel microcolumn agglutination method 
exhibited higher scores, but they were not statistically different 
from those presented by all other enhancers. Table 1 shows 
mean scores for the different antibodies using each selected 
method. Figures 1 and 2 summarize the data.
After the implementation of the type and screen routine 
associated with the 5-minute IAT-XM protocol using a LISS-
albumin enhancer, we had 2080 elective surgeries: 360 RBC 
units were crossmatched and only 81 were not used during 
the surgery. Three months before the implementation of this 
protocol, we had a C:T ratio of 2.74 (2040 elective surgeries, 
795 units crossmatched and 290 units transfused). Our C:T 
ratio fell from 2.74 to 1.29 (p < 0.001) in 3 months.
After the implementation of the 5-minute IAT-XM 
protocol, no transfusion reactions suggestive of hemolysis were 
reported to the blood bank. In one case, antibody screening 
was negative (gel microcolumn agglutination method) and 
IAT-XM was positive. The antibody identified after the 
performance of 16°C antibody screening (tube method) was 
an anti-M without activity at 37°C. In all other cases, IAT-XM 
was negative.
Discussion
Our results demonstrate that the required 37°C 
incubation time for detection of significant RBC alloantibodies 
can be decreased to 5 minutes when using a LISS-albumin 
enhancement medium, without loss of sensitivity or specificity. 
This strategy improved our C:T ratio, an important quality 
indicator of blood utilization, as unexpected needs for urgent 
transfusions directed to surgical patients could be met in less 
than 10 minutes.
Reducing time without losing sensitivity in RBC antigen-
antibody reactions was always a subject of discussion in 
the literature before the emergence of the gel microcolumn 
agglutination method. PEG and LISS, either isolated or 
combined with albumin, are the most widely used enhancement 
media and intensify RBC sensitization while decreasing the 
required incubation time of 60 to 90 minutes (conventional 
tube method) to 15 to 20 minutes.3 Even though extending 
the incubation time in the presence of enhancers may increase 
the detection of antibodies directed against antigens of clinical 
significance,4 extending this time to more than 40 minutes 
may result in a paradoxical loss of sensitivity.3
Performance of RBC crossmatch between donor and 
recipient before transfusion is suggested either when the 
antibody screen is positive or when the risk of previous 
alloimmunization is higher than usual (multiply transfused 
patients and multiparous). There are a considerable number 
of reports of hemolytic transfusion reactions caused by 
antibodies that were not detected by antibody screen or by 
IS-XM, but that would have been detected by IAT-XM.5–8 
Even though those antibodies mainly are cold-reactive or 
are against low-incidence antigens, the odds of encountering 
them increase in patients who are immunologic responders 
and consequently prone to RBC alloimmunization.9 Indeed, 
the decision to eliminate IAT-XM is associated with a risk of 
hemolytic transfusion reactions of 1:2000 transfused units,10 
which is a significant value, especially in large transfusion 
laboratories.
The IS-XM approach is suitable for detecting donor-
patient ABO incompatibilities and may be used in situations 
when antibody screening is negative. However, there is the 
Table 1. Performance of different IAT methods in detecting clinically significant antibodies*
Antibody  
(number of samples)
Enhancer 1 (LISS-albumin): 
5-min incubation
Enhancer 2 (LISS-albumin): 
15-min incubation
Enhancer 3 (PEG):  
15-min incubation Gel Tube: 60-min incubation
Anti-D (50) 9.32 ± 0.79 9.3 ± 1.18 9.18 ± 0.92 9.52 ± 0.93 5.64 ± 1.27
Anti-Jka (12) 3.34 ± 2.23 4 ± 2.89 3.92 ± 1.88 4.25 ± 3.17 1.67 ± 1.37
Anti-Fya (11) 6.82 ± 2.75 6 ± 2.24 6 ± 2.28 6 ± 2.24 2.91 ± 1.87
Anti-Jkb (4) 8.5 ± 1 8.5 ± 1 6.5 ± 1.73 8 ± 0 4 ± 0
Anti-c (11) 12 ± 0 12 ± 0 11.81 ± 0.6 12 ± 0 11.81 ± 0.6
Anti-K (48) 9.38 ± 1.61 9.15 ± 1.51 8.75 ± 1.64 7.48 ± 1.89 5.27 ± 1.97
IAT = indirect antiglobulin test; LISS = low-ionic-strength saline; PEG = polyethylene glycol.
*Mean ± standard deviation.
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substantial risk of not detecting an A2B (donor)-B (recipient) 
mismatch or the presence of an alloantibody against a low-
incidence antigen.11 In countries where IAT-XM is required for 
all patients with a previous history of pregnancy or transfusion, 
as in ours (Brazil), or in areas where the incidence of some low-
incidence antigens is higher owing to ethnic characteristics, a 
5-minute IAT-XM may be a less time-consuming and more 
effective strategy than a 15-minute IAT-XM.
Our present results indicate that the LISS-albumin 
enhancement medium detects clinically significant antibodies 
after 5 minutes of incubation and that the intensity of reactions 
did not differ from that presented by this same enhancer or 
by PEG after 15 minutes of incubation. After implementation 
of routine type and screen testing on samples from surgical 
patients and of preparing RBC units only after intraoperation 
requests, we were able to reduce significantly the number of 
units that were prepared and not transfused. In our country 
this strategy is of great importance, as our legislation requires 
IAT-XM for all recipients who have ever been transfused, 
pregnant, or alloimmunized. As a referral hospital, we have 
plenty of previously transfused or pregnant patients, and 
preparing and reserving RBC units for all of them compromised 
our blood supplies.
In conclusion, crossmatch incubation time can be reduced 
to 5 minutes with the use of LISS-albumin enhancement 
medium. We suggest this strategy be used to quickly prepare 
RBC units for surgical patients, maintaining transfusion safety 
without compromising blood supplies.
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Fig. 1 Mean scores ± 95 percent confidence interval (CI) of antigen-antibody reactions using different indirect antiglobulin test methods 
for the detection of anti-D, -Jka, and -Fya. Enhancers 1, 2, and 3 had a performance similar to that of gel testing. Conventional tube testing 
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Fig. 2 Mean scores ± 95 percent confidence interval (CI) of antigen-antibody reactions using different indirect antiglobulin test methods 
for the detection of anti-Jkb, -c, and -K. Enhancers 1, 2, and 3 had a performance similar to that of gel testing. Conventional tube testing 



















Error bars: 95% Cl
12
IMMUNOHEMATOLOGY, Volume 30, Number 1, 2014 5
References
 1. Rumsey DH, Ciesielski DJ. New protocols in serologic 
testing: a review of techniques to meet today’s challenges. 
Immunohematology 2000;16:131–7.
 2. Roback JD, Grossman BJ, Harris T, Hillyer CD. Technical 
manual. 17th ed. Bethesda, MD: American Association of 
Blood Banks, 2011.
 3. Jørgensen J, Nielsen M, Nielsen CB, Nørmark J. The influence 
of ionic strength, albumin and incubation time on the sensitivity 
of the indirect Coombs’ test. Vox Sang 1979;36:186–91.
 4. Skaik YA. Detection of Rh antibodies using two low ionic 
diluents: extension of the incubation time and the number of 
Rh antibodies detected. J Postgrad Med 2008;54:4–6.
 5. Reznicek MJ, Cordle DG, Strauss RG. A hemolytic reaction 
implicating Sda antibody missed by immediate spin 
crossmatch. Vox Sang 1992;62:173–5.
 6. Judd WJ, Steiner EA, Abruzzo LV, et al. Anti-i causing acute 
hemolysis following a negative immediate-spin crossmatch. 
Transfusion 1992;32:572–5.
 7. Wise SC, Larson PJ, Cook LO. Antibodies to low-incidence 
antigens and elimination of the antihuman globulin phase of 
the crossmatch-case report: anti-Wra. Immunohematology 
1997;13:20–2.
 8. Koshy R, Patel B, Harrison JS. Anti-Kpa-induced severe 
delayed hemolytic transfusion reaction. Immunohematology 
2009;25:44–7.
 9. Higgins JM, Sloan SR. Stochastic modeling of human RBC 
alloimmunization: evidence for a distinct population of 
immunologic responders. Blood 2008;112:2546–53.
 10. Judd WJ, Fullen DR, Steiner EA, Davenport RD, Knafl PC. 
Revisiting the issue: can the reading for serologic reactivity 
following 37 degrees C incubation be omitted? Transfusion 
1999;39:295–9.
 11. Chapman JF, Milkins C, Voak D. The computer crossmatch: 
a safe alternative to the serological crossmatch. Transfus Med 
2000;10:251–6.
Carla Luana Dinardo, MD, PhD, student (corresponding author), 
Chief of Immunohematology Division, Sílvia Leão Bonifácio, MSc 
student, Chief of Immunohematology Quality Control Department, 
and Alfredo Mendrone Júnior, MD, PhD, Director of Fundação Pró-
Sangue/Hemocentro de São Paulo, Avenida Dr. Enéas de Carvalho 
Aguiar, 155—1st floor, Cerqueira César, São Paulo—SP, Brazil 
05403-000.
Rapid technique for IAT-crossmatch
